VeriMomHamilelikte salicylamide kullanmaktan kaçınmalı mıyım? | VeriMom
ECHA REACH/registration data include Repr.2 / H361 notifications for salicylamide (CAS 65-45-2) submitted by registrants (not a harmonised Annex VI classification). This supports a 'suspected' reproductive hazard (h=2) but is not harmonised by the Commission. Mechanistic concern is class-based/theoretical (m=1) because salicylamide is a salicylate-related compound and salicylates are known to cross the placenta and be systemically available; direct mechanistic reproductive data for salicylamide are limited. Exposure from typical topical cosmetic use is expected to be low but measurable (evidence for dermal cosmetic exposure is limited), so e=1.
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- salicylamide hamilelikte güvenli mi?
- ECHA REACH/registration data include Repr.2 / H361 notifications for salicylamide (CAS 65-45-2) submitted by registrants (not a harmonised Annex VI classification). This supports a 'suspected' reproductive hazard (h=2) but is not harmonised by the Commission. Mechanistic concern is class-based/theoretical (m=1) because salicylamide is a salicylate-related compound and salicylates are known to cross the placenta and be systemically available; direct mechanistic reproductive data for salicylamide are limited. Exposure from typical topical cosmetic use is expected to be low but measurable (evidence for dermal cosmetic exposure is limited), so e=1.
- salicylamide emzirirken güvenli mi?
- Registrants have notified H361 (Repr.2) for salicylamide; salicylate metabolites are known to be excreted in human milk (class-based evidence), so a suspected hazard to nursing infants is appropriate (h=2) but this is based on registrant classification and read-across from salicylates rather than a harmonised/regulatory SCCS/CIR conclusion for salicylamide specifically. Systemic exposure after topical use is likely low but non-zero (e=1).
- salicylamide bebek cildi için güvenli mi?
- Hazard (h) and mechanism (m) are kept the same as adult because there is no infant-specific evidence to upscore hazard or mechanism. Exposure (e) is increased by +1 for infants (e=2) per your rules because infant skin has higher surface‑area‑to‑weight and an immature barrier and salicylamide is a small molecule with some dermal absorption potential; therefore infant dermal exposure is moderately greater than adult.
- VeriMom salicylamide nasıl puanlıyor?
- VeriMom salicylamide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
- Hamilelikte salicylamide yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.